Mass Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based national pharmaceutical manufacturer and marketer with domestic and international operations.
Mass Pharma products in Pakistan
Mass Pharma (Pvt) Ltd has 120 medicine presentations registered in Pakistan under 70 brands, covering 59 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are Amodip (Amlodipine, Amlodipine + Hydrochlorothiazide), Maclexin (Cephalexin), Mink (Amikacin) and Anabact (Metronidazole). 120 products have an official DRAP price on MedInfoBase. See all 70 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Mass Pharma (Private) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- 17-KM Ferozepur Road, Lahore, Pakistan
- Website
- masspharma.com ↗
- Phone
- +92 42 35824881-4; +92 322 4873081
- mass@masspharma.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Mass Pharma (Pvt) Ltd. is priced against the market
103 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Acetamol Infusion 100mlRegistry verified | Paracetamol | — | — | — | 011407-EXOfficial source ↗ | No indexed price | — | — |
| Adoxa | Doxycycline | 100 mg | Tablet | 3x10 | 024378 | PKR 291.21 | PKR 9.71/tablet | 🔒 Pharma Pro |
| Aerius Plus TabletsRegistry verified | Ebastine | — | — | — | 069297Official source ↗ | No indexed price | — | — |
| Amodip | Amlodipine | 5 mg | Tablet | 3x10 | 020864 | PKR 412.67 | PKR 13.76/tablet | 🔒 Pharma Pro |
| Amodip | Amlodipine | 5 mg | Tablet | 2x10 | 020864 | PKR 275.51 | PKR 13.78/tablet | 🔒 Pharma Pro |
| Amodip | Amlodipine | 10 mg | Tablet | 3x10 | 020865 | PKR 807.68 | PKR 26.92/tablet | 🔒 Pharma Pro |
| Amodip | Amlodipine | 10 mg | Tablet | 2x10 | 020865 | PKR 538.89 | PKR 26.94/tablet | 🔒 Pharma Pro |
| Amodip | Amlodipine | 2.5 mg | Tablet | 2x10 | 021360 | PKR 173.98 | PKR 8.70/tablet | 🔒 Pharma Pro |
| Amodip | Amlodipine + Hydrochlorothiazide | 5 mg + 12.5 mg | Tablet | 2x10 | 060302 | PKR 223.94 | PKR 11.20/tablet | 🔒 Pharma Pro |
| Amorin | Azathioprine | 50 mg | Tablet | 1x10 | 026130 | PKR 139.54 | PKR 13.95/tablet | 🔒 Pharma Pro |
| Amorin | Azathioprine | 50 mg | Tablet | 10x10 | 026130 | PKR 3,516.04 | PKR 35.16/tablet | 🔒 Pharma Pro |
| Amotac | Enalapril | 10 mg | Tablet | 2x10 | 026127 | PKR 125.51 | PKR 6.28/tablet | 🔒 Pharma Pro |
| Anabact | Metronidazole | 0.75 % | Gel | 5gm | 027692 | PKR 239.08 | PKR 47.82/g | 🔒 Pharma Pro |
| Anabact | Metronidazole | 0.75 % | Gel | 15gm | 027692 | PKR 398.46 | PKR 26.56/g | 🔒 Pharma Pro |
| Anabact | Metronidazole | 0.75 % | Gel | 30gm | 027692 | PKR 478.15 | PKR 15.94/g | 🔒 Pharma Pro |
| Aqua | Water for Injection | 5 mL | Injection | 5mlx100 | 020875 | PKR 735.34 | PKR 1.47/mL | 🔒 Pharma Pro |
| Blaze | Losartan | 50 mg | Tablet | 2x10 | 029368 | PKR 471.12 | PKR 23.56/tablet | 🔒 Pharma Pro |
| Blaze Plus | Losartan + Hydrochlorothiazide | 50 mg + 12.5 mg | Tablet | 2x10 | 029369 | PKR 682.48 | PKR 34.12/tablet | 🔒 Pharma Pro |
| Cefax | Cefotaxime | 250 mg | Injection | 1x1 | 024261 | PKR 110.89 | PKR 110.89/vial/unit | 🔒 Pharma Pro |
| Cefax | Cefotaxime | 1 g | Injection | 1x1 | 027132 | PKR 300.58 | PKR 300.58/vial/unit | 🔒 Pharma Pro |
| Cefazid | Ceftazidime | 250 mg | Injection | 1x1 | 024177 | PKR 167.85 | PKR 167.85/vial/unit | 🔒 Pharma Pro |
| Cefazid | Ceftazidime | 1 g | Injection | 1x1 | 027130 | PKR 479.57 | PKR 479.57/vial/unit | 🔒 Pharma Pro |
| Celestin | Loratadine | 10 mg | Tablet | 1x10 | 024379 | PKR 227.18 | PKR 22.72/tablet | 🔒 Pharma Pro |
| Chemone Dry Powder Injection 1.0gm IV/IMRegistry verified | Cefoperazone (As Sodium), Sulbactam (As Sodium) | — | — | — | 041878Official source ↗ | No indexed price | — | — |
| Chemone Dry Powder Injection 2.0gm IV/IMRegistry verified | Cefoperazone (As Sodium), Sulbactam (As Sodium) | — | — | — | 041879Official source ↗ | No indexed price | — | — |
| Clintol | Loratadine | 10 mg | Tablet | 1x10 | 022868 | PKR 255.17 | PKR 25.52/tablet | 🔒 Pharma Pro |
| Co-Amotac | Hydrochlorothiazide | 10 mg | Tablet | 2x10 | 038346 | PKR 211.14 | PKR 10.56/tablet | 🔒 Pharma Pro |
| De-Nile Plus | Telmisartan + Hydrochlorothiazide | 40 mg + 12.5 mg | Tablet | 2x7 | 060305 | PKR 640.24 | PKR 45.73/tablet | 🔒 Pharma Pro |
| De-Nile Plus | Telmisartan + Hydrochlorothiazide | 80 mg + 12.5 mg | Tablet | 2x7 | 060306 | PKR 1,208.20 | PKR 86.30/tablet | 🔒 Pharma Pro |
| De-Nile Plus | Telmisartan + Hydrochlorothiazide | 20 mg + 12.5 mg | Tablet | 1x10 | 063148 | PKR 274.69 | PKR 27.47/tablet | No comparator |
| Dee 50k Soft Gelatin Vitamin D3 | Cholecalciferol | 50000 IU | Capsule | 100's | 093452 | PKR 383.44 | PKR 3.83/capsule | 🔒 Pharma Pro |
| Dinaphin | Ceftriaxone | 250 mg | Injection | 1x1 | 024258 | PKR 247.84 | PKR 247.84/vial/unit | 🔒 Pharma Pro |
| Dinaphin | Ceftriaxone | 1 g | Injection | 1x1 | 027124 | PKR 595.63 | PKR 595.63/vial/unit | 🔒 Pharma Pro |
| Dinaphin | Ceftriaxone | 500 mg | Injection | 1x1 | 030876 | PKR 351.10 | PKR 351.10/vial/unit | 🔒 Pharma Pro |
| Dipcort | Miconazole + Hydrocortisone | 2% + 1% | Cream | 15gm | 027129 | PKR 130.02 | PKR 8.67/g | 🔒 Pharma Pro |
| Dipsone | Betamethasone | 0.05% | Ointment | 15gm | 027127 | PKR 142.53 | PKR 9.50/g | 🔒 Pharma Pro |
| Effidex C OintmentSource observed | Betamethasone | — | — | 15gm | 104906Official source ↗ | No indexed price | — | — |
| Effidex C Ointment Betamethasone / CalcipotriolSource observed | — | — | — | 15gm | 104906Official source ↗ | No indexed price | — | — |
| Enclot | Clopidogrel | 75 mg | Tablet | 1x10 | 046362 | PKR 209.39 | PKR 20.94/tablet | 🔒 Pharma Pro |
| Enclot Plus | Clopidogrel + Aspirin | 75 mg + 75 mg | Tablet | 1x10 | 060303 | PKR 259.47 | PKR 25.95/tablet | 🔒 Pharma Pro |
| Entawin | Entecavir | 0.5 mg | Tablet | 3x10 | 069489 | PKR 21,357.57 | PKR 711.92/tablet | 🔒 Pharma Pro |
| Ezonex | Azithromycin | 250 mg | Capsule | 2x5 | 026672 | PKR 544.41 | PKR 54.44/capsule | 🔒 Pharma Pro |
| Ezonex | Azithromycin | 250 mg | Capsule | 1x6 | 026672 | PKR 326.65 | PKR 54.44/capsule | 🔒 Pharma Pro |
| Ezonex | Azithromycin | 500 mg | Tablet | 1x6 | 106148 | PKR 412.69 | PKR 68.78/tablet | 🔒 Pharma Pro |
| Favrizol | Fluconazole | 150 mg | Capsule | 1x4 | 026123 | PKR 1,510.41 | PKR 377.60/capsule | 🔒 Pharma Pro |
| Flute Caps | Fluoxetine | 20 mg | Capsule | 1x10 | 022870 | PKR 229.74 | PKR 22.97/capsule | 🔒 Pharma Pro |
| Flymol Infusion 100mlRegistry verified | Metronidazole | — | — | — | 011406-EXOfficial source ↗ | No indexed price | — | — |
| Grow-D | Cholecalciferol | 5 mg | Injection | 1mlx5 | 069484 | PKR 977.84 | PKR 195.57/mL | 🔒 Pharma Pro |
| Grow-D | Cholecalciferol | 5 mg | Injection | 1mlx1 | 069484 | PKR 230.33 | PKR 230.33/mL | 🔒 Pharma Pro |
| Grow-D | Cholecalciferol | 5 mg | Injection | 1mlx10 | 069484 | PKR 743.31 | PKR 74.33/mL | 🔒 Pharma Pro |
All 70 Mass Pharma brands in Pakistan
- Adoxa Doxycycline · 100 mg tablet
- Amodip Amlodipine, Amlodipine + Hydrochlorothiazide · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Amorin Azathioprine · 50 mg tablet
- Amotac Enalapril · 10 mg tablet
- Anabact Metronidazole · 0.75 % gel
- Aqua Water for Injection · 5 mL injection
- Blaze Losartan · 50 mg tablet
- Blaze Plus Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
- Cefax Cefotaxime · 1 g injection, 250 mg injection
- Cefazid Ceftazidime · 1 g injection, 250 mg injection
- Celestin Loratadine · 10 mg tablet
- Clintol Loratadine · 10 mg tablet
- Co-Amotac Hydrochlorothiazide · 10 mg tablet
- De-Nile Plus Telmisartan + Hydrochlorothiazide · 20 mg + 12.5 mg tablet, 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- Dee 50k Soft Gelatin Vitamin D3 Cholecalciferol · 50000 IU capsule
- Dinaphin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Dipcort Miconazole + Hydrocortisone · 2% + 1% cream
- Dipsone Betamethasone · 0.05% ointment
- Enclot Clopidogrel · 75 mg tablet
- Enclot Plus Clopidogrel + Aspirin · 75 mg + 75 mg tablet
- Entawin Entecavir · 0.5 mg tablet
- Ezonex Azithromycin · 250 mg capsule, 500 mg tablet
- Favrizol Fluconazole · 150 mg capsule
- Flute Caps Fluoxetine · 20 mg capsule
- Grow-D Cholecalciferol · 5 mg injection
- H-Masquine Hydroxychloroquine · 200 mg tablet
- Haemolok Tranexamic acid · 250 mg injection, 500 mg injection
- Hitroxin Ciprofloxacin · 200 mg infusion, 250 mg tablet, 500 mg tablet
- Isotrate Isosorbide mononitrate · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Itranex Itraconazole · 100 mg capsule
- Levite Levofloxacin · 250 mg tablet, 500 mg infusion, 500 mg tablet
- Lopi-Mass Lopinavir + Ritonavir · 50 mg + 50 mg tablet
- Lotricort Betamethasone + Clotrimazole · 0.05 % + 1.0 % cream
- Lotricort Betamethasone Dipro Betamethasone + Clotrimazole · 0.05 % + 1.0 % cream
- Lotricort-G Betamethasone + Clotrimazole · 1 % + 0.1 % cream
- Lotricort-G Betamethasone Clotrimazole · 0.05 % cream
- Lotrigen Clotrimazole · 1% cream
- Lotrigen HC Clotrimazole · 1 % cream
- Lumifal Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Lumifal Plus Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Maclexin Cephalexin · 125 mg drops, 125 mg/5 mL suspension, 250 mg capsule
- Malin Permethrin · 5 % lotion, 5% lotion
- Masdipine Nifedipine · 20 mg tablet
- Masdipine 30mg SR Nifedipine · 30 mg tablet
- Masdipine 60mg SR Nifedipine · 60 mg tablet
- Masplex Plus Iron protein succinylate + Folic acid · 400 mg + 2.5 mg tablet
- Massvir Oseltamivir · 75 mg capsule
- Mectimite Ivermectin · 3 mg tablet, 6 mg tablet
- Mink Amikacin · 100 mg injection, 25 mg injection, 250 mg injection
- Mobik Moxifloxacin · 400 mg tablet, 400 mg injection
- Mupas Mupirocin · 2% cream, 2% ointment
- Nelzim . Cephazolin Sodium Cefazolin · 1 g injection, 250 mg injection
- Neotret Acitretin · 10 mg capsule
- Pepzol Omeprazole · 20 mg capsule
- Probase Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Raban Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
- Spectrazole Betamethasone + Clotrimazole · 0.05 % + 1.0 % cream
- Spectrazole-G Betamethasone Clotrimazole · 0.05 % cream
- Spril Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Tiracef Cefuroxime · 250 mg injection, 750 mg injection
- Triazolin Fluconazole · 150 mg capsule
- Verient Iron sucrose · 100 mg injection
- Verticil Terbinafine · 1 % cream, 125 mg cream, 250 mg cream
- Xamogine Lamotrigine = · 50 mg tablet
- Xaslexx Bupropion · 150 mg tablet, 75 mg tablet
- Zafranil Clomipramine · 75 mg tablet
- Zalozapine Clozapine · 100 mg tablet
- Zalprocid Valproic acid · 250 mg tablet
- Zedone Risperidone · 2 mg tablet
- Zedopa CR Carbidopa + Levodopa · 25 mg + 250 mg tablet
Mass Pharma: common questions
How many products does Mass Pharma have in Pakistan?
Mass Pharma (Pvt) Ltd has 120 registered medicine presentations in Pakistan, sold under 70 brands and covering 59 generic medicines.
What are the main brands of Mass Pharma?
By number of registered strengths and packs, its largest brands are Amodip (Amlodipine, Amlodipine + Hydrochlorothiazide), Maclexin (Cephalexin), Mink (Amikacin), Anabact (Metronidazole) and De-Nile Plus (Telmisartan + Hydrochlorothiazide). This is not a sales ranking.
Which therapy areas does Mass Pharma cover?
The most products are in Anti-infectives (65), Cardiovascular (22), CNS & mental health (9), Hematology & thrombosis (7) and Vitamins, minerals & nutrition (6).
Where can I see Mass Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.